Answer Summary

Members from around the world discussed the stark differences in accessing HIV medications, with those in Kenya receiving free ARVs while many... Read more

Members from around the world discussed the stark differences in accessing HIV medications, with those in Kenya receiving free ARVs while many in the United States face significant financial and bureaucratic barriers unless they have excellent insurance or qualify for assistance programs like Ryan White or state ADAP programs. Several members shared practical strategies for affording treatment, including contacting drug manufacturers directly for copay assistance cards (with one member receiving a $7,000 Gilead coupon for Biktarvy), working with case managers to navigate patient assistance programs that require extensive financial documentation, and exploring offshore pharmacies as a last resort at around $180 monthly. A recurring theme was the frustration and injustice of life-saving medications being inaccessible to many Americans due to cost, alongside encouragement to exhaust all assistance options and the recognition that some members with slow disease progression have temporary flexibility to delay treatment while exploring affordable access.